This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Symptoms and signs involving appearance and behaviour
R18_SYMPTOMS_SIGNS_INVOLVI_APPEA_BEHVI
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
369 |
4. Check minimum number of eventsNone |
369 |
5. Include endpointsNone |
369 |
6. Filter based on genotype QC (FinnGen only) |
321 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R4[0-6]
- Name in latin
- Symptomata et signa ad habitum corporis et modum se gerendi pertinentia
Similar endpoints
↥List of similar endpoints to
Symptoms and signs involving appearance and behaviour
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving cognition, perception, emotional state and behaviour
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 321 | 210 | 111 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.05 |
| Median age at first event (years) | 49.79 | 44.88 | 59.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 335
- Matched controls
- 3350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
+∞
246.4
205
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
11.5
83.5
103
125
R56.8
ICD-10 Finland
Other and unspecified convulsions
14.2
77.2
78
70
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
17.5
70.9
62
43
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
11.8
56.0
62
63
G40.9
ICD-10 Finland
Epilepsy, unspecified
13.2
44.7
45
39
AA1AD
NOMESCO Finland
CT of head and brain
4.8
43.1
145
458
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.1
42.7
74
129
N03AG01
ATC
valproic acid; systemic, rectal
8.4
42.6
61
86
N05AX08
ATC
risperidone; systemic
6.9
40.0
70
123
N03AX14
ATC
levetiracetam; systemic
15.5
38.8
35
25
R42
ICD-10 Finland
Dizziness and giddiness
5.6
37.5
85
191
N05AH03
ATC
olanzapine; systemic
7.3
37.5
61
99
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.9
35.4
61
105
N03AF02
ATC
oxcarbazepine; oral
10.9
33.6
38
39
R55
ICD-10 Finland
Syncope and collapse
5.3
31.5
74
170
N03AX09
ATC
lamotrigine; oral
7.1
31.0
51
83
R46.6
ICD-10 Finland
Undue concern and preoccupation with stressful events
330.7
30.3
30
*
N05AF03
ATC
chlorprothixene; systemic
11.0
28.7
32
32
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
7.7
28.3
42
61
N05AX12
ATC
aripiprazole; systemic
7.4
27.9
43
65
R46.2
ICD-10 Finland
Strange and inexplicable behaviour
+∞
27.5
26
*
N05AH04
ATC
quetiapine; oral
3.8
27.3
111
385
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.6
26.3
74
196
N03AE01
ATC
clonazepam; systemic
6.9
25.1
41
66
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
22.2
24.9
36
18
XA800
NOMESCO Finland
Neuropsychological investigation
7.7
23.8
35
50
N05BA04
ATC
oxazepam; oral
3.2
22.1
129
552
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
21.8
78
245
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
20.7
21.7
32
17
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.6
21.7
37
62
N06AX11
ATC
mirtazapine; oral
3.0
21.7
156
750
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.0
21.3
34
53
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.0
21.3
40
74
N06AX16
ATC
venlafaxine; oral
3.6
20.8
84
285
S06.0
ICD-10 Finland
Concussion
4.0
20.6
69
206
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.2
20.0
44
94
R46.7
ICD-10 Finland
Verbosity and circumstantial detail obscuring reason for contact
+∞
20.0
19
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
19.8
74
238
N05AA02
ATC
levomepromazine; systemic
6.7
19.3
32
52
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.5
19.1
78
266
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.5
18.0
75
258
R46.4
ICD-10 Finland
Slowness and poor responsiveness
+∞
17.9
17
*
R41.0
ICD-10 Finland
Disorientation, unspecified
39.1
17.8
22
6
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.9
17.8
60
179
N06AB04
ATC
citalopram; systemic
3.1
17.5
94
377
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.4
17.4
47
119
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.5
17.3
35
69
K59.0
ICD-10 Finland
Constipation
5.4
16.8
35
71
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
16.8
176
993
SPAT1249
SPAT
Treatment-related counselling outside office
2.6
16.7
168
929
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.9
16.5
31
57
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
6.3
16.5
29
50
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
7.5
16.3
24
34
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
16.3
52
149
N05CD07
ATC
temazepam; oral
4.0
16.2
50
140
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.5
16.1
26
18
R53
ICD-10 Finland
Malaise and fatigue
2.7
16.1
122
585
L28
ICPC
Limited function/disability (L)
3.2
16.0
78
294
N05BA06
ATC
lorazepam; systemic, sublingual
5.5
15.9
32
63
R46.0
ICD-10 Finland
Very low level of personal hygiene
+∞
15.7
15
*
P29
ICPC
Psychological sympt/compl other
3.7
15.7
55
168
SPAT1301
SPAT
No procedures
2.6
15.4
134
685
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
15.0
126
632
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
15.1
14.8
24
17
R11
ICD-10 Finland
Nausea and vomiting
3.7
14.5
50
151
N05BA01
ATC
diazepam; systemic, rectal
3.2
13.9
63
226
N06AX21
ATC
duloxetine; oral
3.2
13.7
60
211
R46.5
ICD-10 Finland
Suspiciousness and marked evasiveness
+∞
13.6
13
*
183
Kela drug reimbursment
Lamotrigin and topiramate
27.0
13.5
18
7
Z2445
NOMESCO Finland
Psychologist
4.7
13.4
32
73
ZYC01
NOMESCO Finland
Remote contact by phone
4.0
13.4
40
109
N05BA09
ATC
clobazam; oral
41.9
13.3
16
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.9
13.1
30
66
N06AB06
ATC
sertraline; oral
3.0
12.9
65
248
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
12.8
105
515
WX723
NOMESCO Finland
CPAP therapy
4.9
12.6
29
64
N03AX12
ATC
[U] gabapentin; oral
2.9
12.5
70
283
SPAT1263
SPAT
Sampling
2.3
12.4
168
1022
SPAT1240
SPAT
Therapeutic discussion
3.0
12.4
63
241
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
12.3
89
410
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.3
12.3
21
35
K59.09
ICD-10 Finland
Constipation, unspecified
4.3
12.2
33
83
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.3
12.2
33
83
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.7
11.7
28
64
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
14.3
11.6
19
14
SPAT1254
SPAT
Administration of medicine
2.8
11.6
68
281
R40.2
ICD-10 Finland
Coma, unspecified
124.1
11.5
12
*
N06AB10
ATC
escitalopram; oral
2.4
11.5
97
479
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.8
11.3
21
38
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
11.3
81
370
ZXE00
NOMESCO Finland
One hour or less
2.2
11.3
149
889
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.3
11.3
45
149
TAB00
NOMESCO Finland
Lumbar puncture
4.6
11.2
27
62
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
11.1
88
421
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.9
11.1
59
231
IGV01
NOMESCO Finland
Psychiatric network contact
14.6
11.1
18
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.1
11.0
51
185
A06AD11
ATC
lactulose; oral
3.0
10.9
53
197
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.3
10.9
29
72
F05.9
ICD-10 Finland
Delirium, unspecified
18.6
10.8
16
9
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
10.6
63
262
N03AF01
ATC
carbamazepine; oral, rectal
4.7
10.5
25
57
N03AX11
ATC
topiramate; oral
7.9
10.4
23
31
Z3231
NOMESCO Finland
Registered nurse
2.3
10.4
108
581
Z2446
NOMESCO Finland
Social worker
3.5
10.3
37
114
SPAT1243
SPAT
Psychiatric/psychological examination
4.9
10.2
23
50
SPAT1260
SPAT
Consultation of another employee
2.5
10.1
77
360
N03AX16
ATC
[U] pregabalin
2.4
10.1
83
402
ZY000
NOMESCO Finland
Hospital inpatient
11.1
9.9
18
17
JN3AD
NOMESCO Finland
Abdominal CT examination
2.8
9.9
55
220
N04AA02
ATC
biperiden; systemic
10.0
9.9
19
20
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.7
9.9
32
92
SPAT1053
SPAT
Memory test
3.1
9.8
44
156
IHZ05, ,
SPAT
3.7
9.7
32
93
F20.9
ICD-10 Finland
Schizophrenia, unspecified
8.8
9.7
20
24
Z00.0
ICD-10 Finland
General medical examination
2.4
9.7
84
417
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.4
9.6
36
114
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.0
9.5
44
159
N05AB03
ATC
perphenazine; systemic, rectal
5.4
9.5
19
37
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
9.5
66
296
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
22.5
9.4
13
6
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
9.9
9.4
18
19
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
9.3
102
557
SPAT1262
SPAT
Handing over of treatment supplies
2.5
9.3
64
285
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.1
9.3
41
144
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.9
9.3
46
173
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.2
9.2
19
38
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
9.2
142
884
P20
ICPC
Memory disturbance
3.0
9.1
43
157
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
9.1
74
356
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.4
9.1
23
55
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.5
9.0
32
98
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
9.0
145
914
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
9.0
122
722
N06AB03
ATC
fluoxetine; oral
2.6
8.9
56
238
SPAT1360
SPAT
Extensive global examination
3.8
8.9
28
79
N06AX12
ATC
bupropion; oral
3.0
8.9
41
148
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.6
8.8
58
252
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.9
8.8
21
32
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
14.5
8.8
14
10
C03CA01
ATC
furosemide; systemic
2.2
8.8
89
470
R52.2
ICD-10 Finland
Other chronic pain
4.8
8.7
20
44
R5140
NOMESCO Finland
Monitoring the use of the aid
2.8
8.6
48
192
R51.80
ICD-10 Finland
Headache
2.3
8.6
80
407
F34.1
ICD-10 Finland
Dysthymia
4.4
8.6
22
53
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.8
8.6
27
76
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
8.6
102
573
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
8.5
79
401
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.3
8.4
22
54
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.3
8.4
22
54
N05AH02
ATC
clozapine; systemic
7.1
8.2
19
28
SPAT1307
SPAT
Psychosocial counselling and guidance
3.0
8.1
38
138
N05AD01
ATC
haloperidol; systemic
7.5
8.1
18
25
N03AX18
ATC
lacosamide; systemic
22.7
8.1
11
5
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
8.0
47
193
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
8.0
36
128
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
13.5
7.9
13
10
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.2
7.9
21
52
UJF32
NOMESCO Finland
Coloscopy
2.2
7.9
82
436
M54.5
ICD-10 Finland
Low back pain
2.0
7.8
132
836
N02BF02
ATC
pregabalin; oral
3.2
7.8
31
102
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
8.3
7.7
16
20
AA5PD
NOMESCO Finland
CT examination of brain pefusion
18.9
7.6
11
6
R41.3
ICD-10 Finland
Other amnesia
12.2
7.6
13
11
C07AB07
ATC
bisoprolol; oral
1.9
7.6
149
989
A28
ICPC
Limited function/disability NOS
2.4
7.6
56
256
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
7.6
59
277
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
7.5
115
702
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
7.5
134
864
P76
ICPC
Depressive disorder
2.8
7.4
38
145
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
7.4
34
122
WZC30
NOMESCO Finland
Teaching
2.3
7.4
64
315
ZY010
NOMESCO Finland
Hospital outpatient
3.2
7.4
29
95
F60.9
ICD-10 Finland
Personality disorder, unspecified
11.2
7.4
13
12
R1250
NOMESCO Finland
Evaluation of functional capability
6.5
7.3
18
29
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.0
7.3
19
33
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
7.3
80
432
F44.5
ICD-10 Finland
Dissociative convulsions
+∞
7.3
7
*
R46
ICD-10 Finland
Symptoms and signs involving appearance and behaviour
+∞
7.3
7
*
N05CF01
ATC
zopiclone; oral
2.0
7.3
107
643
N30.0
ICD-10 Finland
Acute cystitis
2.2
7.3
66
331
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
7.3
88
494
A02BC02
ATC
pantoprazole; systemic
1.9
7.2
218
1654
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
7.2
154
1047
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.8
7.2
17
26
SPAT1234
SPAT
Support of social functional capacity
3.9
7.2
21
56
G44.2
ICD-10 Finland
Tension-type headache
2.3
7.2
62
304
R44.0
ICD-10 Finland
Auditory hallucinations
30.7
7.2
9
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
7.2
69
354
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
7.2
30
102
R06.0
ICD-10 Finland
Dyspnoea
2.0
7.2
95
551
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
7.2
38
148
WX730
NOMESCO Finland
Conventional respirator
12.4
7.1
12
10
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
9.1
7.1
14
16
G47.3
ICD-10 Finland
Sleep apnoea
2.1
7.1
80
437
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.1
7.0
29
98
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
7.0
22
62
P03
ICPC
Feeling depressed
2.4
7.0
52
239
F10.20
ICD-10 Finland
Alcohol dependence currently independent
7.8
7.0
15
20
XF600
NOMESCO Finland
Bloodpressure measurement
3.5
7.0
24
72
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
14.2
6.9
11
8
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.9
6.9
16
24
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
6.9
36
139
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
6.9
37
145
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.3
6.9
26
83
IGY02, ,
SPAT
9.6
6.8
13
14
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.4
6.8
17
40
N05AF05
ATC
zuclopenthixol; systemic
17.1
6.8
10
6
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
6.8
255
2059
SPAT1312
SPAT
General health counselling
1.9
6.8
121
774
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
6.8
32
117
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
6.7
47
210
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.2
6.7
18
45
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
23.0
6.7
9
*
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
23.0
6.7
9
*
XF404
NOMESCO Finland
Ambulatory ECG
3.0
6.7
29
101
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.4
6.6
24
75
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
6.6
24
75
N06AX03
ATC
mianserin; oral
3.7
6.5
21
60
A04
ICPC
Weakness/tiredness general
2.2
6.5
64
330
N06AX26
ATC
vortioxetine; oral
2.7
6.5
35
137
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
6.5
26
86
SPAT1310
SPAT
Counselling related to known health issue
1.9
6.5
119
766
P01
ICPC
Feeling anxious/nervous/tense
2.1
6.5
69
368
W19
ICD-10 Finland
Unspecified fall
2.6
6.5
38
156
G41.9
ICD-10 Finland
Status epilepticus, unspecified
71.2
6.4
7
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.2
6.4
17
42
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.3
6.4
24
76
N05BE01
ATC
buspirone; oral
5.4
6.4
18
35
HMAK, ,
NOMESCO Finland
2.4
6.4
48
221
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.8
6.4
15
23
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
6.4
42
182
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
5.7
6.4
17
31
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
6.3
53
256
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.3
97
589
ICB06, ,
NOMESCO Finland
18.4
6.3
9
5
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
6.3
81
463
N06AB05
ATC
paroxetine; oral
3.1
6.3
26
88
A02BC01
ATC
omeprazole; systemic
1.9
6.3
91
542
N07
ICPC
Convulsion/seizure
27.2
6.3
8
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.5
6.2
17
32
ZXD05
NOMESCO Finland
Urgent procedure
1.9
6.2
104
649
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
6.2
87
512
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.7
6.2
34
135
SPAT1131
SPAT
Colonoscopy
4.3
6.2
16
39
R4110, ,
SPAT
2.4
6.1
46
212
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.5
6.1
21
63
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
8.8
6.1
12
14
N02BF01
ATC
gabapentin; oral
2.5
6.1
41
180
IGP01
NOMESCO Finland
Psychiatric family contact
10.3
6.1
11
11
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
10.3
6.1
11
11
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.0
6.1
17
44
N17
ICPC
Vertigo/dizziness
2.4
6.0
44
200
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
6.0
69
377
WX780
NOMESCO Finland
Remote monitoring CPAP
3.3
6.0
23
74
M79.6
ICD-10 Finland
Pain in limb
1.8
6.0
154
1090
B34.9
ICD-10 Finland
Viral infection, unspecified
3.8
6.0
18
49
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
99
200
6.61
49.92
4.8
3.5
1.21
1.22
mmol/l
0.77
85
172
109
259
5.76
45.93
4.9
3.4
—
—
—
0
0
141
493
4.21
35.57
2.1
1.7
472.73
27659997.78
pmol/l
0.50
113
423
215
1119
3.57
27.98
13.0
11.0
1.15
1.19
inr
0.65
192
897
232
1304
3.53
25.88
20.3
10.3
0.00
0.00
e9/l
0.58
207
1056
225
1259
3.40
24.91
6.2
6.3
1.21
1.21
mmol/l
0.02
166
1091
191
975
3.23
24.66
6.0
3.5
18.10
102.37
ng/l
0.70
128
609
83
270
3.76
22.01
2.2
1.9
371.31
379.59
nmol/l
0.12
78
254
108
420
3.32
21.65
3.3
3.3
0.82
0.82
mmol/l
0.09
101
397
251
1580
3.35
21.23
6.3
4.4
6.20
6.53
mmol/l
2.34
240
1465
173
899
2.91
20.55
4.6
3.2
0.00
0.01
estimate
0.80
95
275
130
589
2.97
19.75
3.9
2.6
8.83
6.81
e6/l
0.40
118
530
162
832
2.83
19.38
5.7
3.8
0.00
0.01
estimate
0.50
106
317
195
1123
2.76
18.36
5.7
5.6
1.21
1.21
mmol/l
0.70
179
1041
165
886
2.70
17.68
2.4
3.2
2.35
2.35
mmol/l
0.33
155
814
89
362
2.99
16.00
2.0
1.6
1659.84
1172.87
nmol/l
2.88
67
275
144
766
2.54
15.17
4.0
2.9
0.24
0.32
e6/l
0.43
117
534
29
55
5.68
14.94
1.7
1.3
4.95
19.33
e6/l
0.56
22
43
182
1106
2.41
14.00
3.9
4.5
35.30
36.34
g/l
1.57
171
1047
189
1181
2.38
13.47
5.4
3.6
0.00
0.02
estimate
1.15
90
285
163
959
2.36
13.31
4.3
3.1
—
—
—
0
0
226
1536
2.45
13.17
5.5
3.7
0.00
0.00
estimate
-0.00
107
332
132
711
2.41
13.14
1.9
1.6
18.84
20.43
nmol/l
0.53
115
605
146
826
2.36
12.96
3.5
2.4
51.51
62.73
u/l
1.24
134
769
24
24
10.68
12.71
4.0
1.5
90.42
88.72
%
0.62
24
24
226
1553
2.40
12.58
5.5
3.7
0.00
4.85
estimate
0.50
108
335
225
1565
2.33
11.85
5.5
3.7
0.00
0.02
estimate
0.79
104
317
120
687
2.16
9.79
3.1
3.4
907.70
1093.53
ng/l
0.24
92
575
123
714
2.14
9.66
2.7
2.1
3.08
2.70
mg/l
1.54
111
614
39
130
3.26
9.63
2.5
3.0
2.35
1.39
mmol/l
0.60
28
95
184
1248
2.05
9.44
2.7
2.4
70.63
76.01
nmol/l
1.76
170
1147
258
1988
2.30
9.42
4.9
3.1
37.29
41.70
u/l
0.94
238
1901
268
2107
2.36
9.18
9.6
7.4
72.85
76.79
u/l
1.55
252
1990
200
1430
1.99
8.49
5.5
6.2
8.71
10.77
umol/l
4.94
189
1356
275
2236
2.28
7.88
6.4
4.3
14.80
14.60
pmol/l
0.77
257
2057
200
1455
1.93
7.80
3.9
3.0
97.55
101.45
ug/l
0.13
184
1383
109
648
2.01
7.74
2.1
1.7
0.95
1.20
mg/l
0.58
75
493
147
969
1.92
7.71
3.5
3.1
33.38
30.06
u/l
0.29
139
922
19
45
4.42
7.58
1.4
2.7
5.95
8.62
pmol/l
0.72
19
45
25
73
3.62
7.55
2.9
1.5
—
—
—
0
0
316
2798
3.28
6.54
27.8
14.7
139.14
139.70
mmol/l
3.04
311
2738
44
193
2.47
6.53
3.7
2.2
5482.37
5122.90
u/l
0.04
13
78
37
150
2.65
6.45
1.9
1.5
0.18
0.33
mg/l
1.41
17
60
316
2802
3.25
6.44
27.5
14.8
3.95
3.94
mmol/l
0.35
310
2731
36
145
2.66
6.35
2.3
1.6
530.77
319.05
mu/l
0.99
31
133
72
399
2.02
6.07
2.6
1.7
1.56
1.35
%
3.50
62
361
49
234
2.28
6.02
2.3
2.4
0.21
0.22
g/l
0.46
42
223
255
2097
1.90
5.91
6.2
3.8
11.16
10.43
mm/h
0.45
242
1954
231
1846
1.81
5.83
8.0
4.2
12992.33
194.73
e6/l
—
6
30
81
480
1.91
5.60
2.3
2.5
2.44
2.44
mmol/l
0.12
75
432
14
24
6.04
5.59
18.5
21.7
1286.71
1486.00
nmol/l
0.42
14
24
72
411
1.96
5.55
2.3
1.9
—
—
—
0
0
209
1636
1.74
5.53
12.0
9.4
4.04
4.02
e9/l
0.04
186
1426
70
401
1.94
5.33
2.3
2.2
2.39
2.35
g/l
0.26
65
370
31
130
2.53
5.06
1.8
1.3
—
—
—
0
0
302
2681
2.28
5.01
25.8
12.7
90.68
87.20
ml/min/173m2
2.11
291
2436
12
21
5.88
4.80
1.2
1.4
0.16
0.16
nmol/l
—
7
14
298
2646
2.14
4.71
7.4
5.2
1.74
1.86
mu/l
1.09
278
2470
19
67
2.95
4.30
1.3
1.3
—
—
—
0
0
18
66
2.83
3.82
1.3
1.7
—
—
—
0
0
60
368
1.77
3.64
2.4
2.2
22.10
23.09
%
0.25
55
344
37
194
2.02
3.61
1.8
1.6
—
—
—
0
0
14
354
0.37
3.54
1.1
1.9
3.11
3.49
ratio
—
7
271
107
773
1.56
3.43
1.5
1.3
1.74
1.36
u/ml
0.16
45
219
9
18
5.11
3.39
1.6
1.2
—
—
—
0
0
14
48
3.00
3.34
1.8
1.2
27.57
5.13
iu/ml
—
7
8
293
2663
1.80
3.20
5.9
4.4
5.82
5.82
mmol/l
0.02
264
2471
55
342
1.73
3.18
4.6
6.4
103.96
104.59
mmol/l
0.38
55
342
13
44
3.03
3.17
1.4
2.0
—
—
—
0
0
12
35
3.52
3.14
1.4
1.4
—
—
—
0
0
6
8
7.61
3.06
1.0
1.1
—
—
—
0
0
144
1132
1.48
3.03
2.3
1.9
94.05
96.73
pmol/l
0.32
88
595
17
70
2.50
2.93
2.1
2.6
—
—
—
0
0
48
294
1.74
2.92
2.2
1.7
—
—
—
0
0
7
13
5.47
2.88
1.1
3.5
64.00
93.23
nmol/l
—
7
13
306
2836
1.91
2.88
27.1
13.1
15.59
22.21
mg/l
5.35
281
2307
31
168
1.93
2.78
3.0
2.4
2.75
6.28
ug/l
2.66
24
145
10
263
0.36
2.76
1.1
1.8
3.02
3.51
mmol/l
—
5
182
6
10
6.09
2.71
2.8
5.5
—
—
—
0
0
17
73
2.40
2.70
1.4
1.8
—
—
—
0
0
17
73
2.40
2.70
1.6
1.5
408.43
277.03
ug/g
—
7
44
45
279
1.71
2.63
2.2
1.8
—
—
—
0
0
79
564
1.52
2.61
1.5
1.3
49.45
27.13
iu/ml
0.42
23
159
5
7
7.23
2.55
1.8
1.9
—
—
—
0
0
10
31
3.29
2.54
3.6
2.3
104.00
105.94
mmol/l
—
10
31
50
327
1.62
2.40
1.9
2.6
4.79
7.80
umol/l
1.69
39
293
163
1353
1.40
2.39
2.8
2.8
—
—
estimate
—
0
0
24
126
1.97
2.37
4.2
2.3
0.67
0.63
%
0.27
24
126
15
65
2.37
2.35
1.2
1.6
0.35
0.41
nmol/l
—
10
53
10
34
3.00
2.30
1.7
1.6
—
—
—
0
0
282
2598
1.54
2.20
4.4
3.9
1.26
1.25
mmol/l
0.06
258
2430
24
130
1.91
2.19
3.3
2.4
25.58
24.13
mmol/l
0.80
24
130
10
36
2.83
2.15
1.5
1.3
—
—
—
0
0
41
264
1.63
2.10
4.2
7.3
0.46
0.57
mmol/l
0.04
35
220
9
31
2.95
2.09
3.9
2.3
1.19
1.18
mmol/l
—
9
31
5
10
5.06
2.08
1.0
1.0
—
—
—
0
0
9
32
2.86
2.01
1.0
1.1
—
—
—
0
0
36
227
1.66
2.01
4.4
7.9
120.75
120.73
g/l
0.00
36
220
5
11
4.60
1.95
1.0
1.0
1115.60
1323.91
miu/ml
—
5
11
9
33
2.77
1.94
1.0
1.1
—
—
—
0
0
6
16
3.80
1.94
3.0
2.8
—
—
—
0
0
5
12
4.21
1.83
2.4
1.3
—
—
—
0
0
5
12
4.21
1.83
2.4
1.2
—
—
—
0
0
32
201
1.65
1.82
3.5
6.5
7.63
8.65
mmol/l
0.38
32
191
9
35
2.61
1.81
1.6
1.5
—
—
—
0
0
278
2583
1.45
1.78
7.6
5.6
39.75
38.30
mmol/mol
1.47
256
2436
12
54
2.27
1.76
1.8
1.9
—
—
—
0
0
312
2974
1.72
1.73
15.3
10.4
24.81
25.59
u/l
0.47
302
2902
99
794
1.35
1.69
4.9
4.1
2.51
9.22
mg/mmol
3.58
59
504
8
31
2.62
1.67
1.1
1.1
—
—
—
0
0
8
31
2.62
1.67
1.0
1.1
—
—
—
0
0
11
49
2.29
1.65
1.8
1.5
—
—
—
0
0
12
56
2.19
1.63
1.7
1.5
—
—
—
0
0
18
308
0.56
1.61
4.4
4.1
24.92
31.04
%
1.80
12
213
8
32
2.54
1.60
1.1
1.1
—
—
—
0
0
19
107
1.82
1.58
1.7
1.5
—
—
—
0
0
5
15
3.37
1.53
2.4
1.3
—
—
—
0
0
5
15
3.37
1.53
1.0
1.1
—
—
—
0
0
68
523
1.38
1.50
1.6
1.3
2.19
9.43
u/ml
2.58
40
203
9
38
2.41
1.46
1.1
1.1
—
—
—
0
0
9
40
2.28
1.41
1.0
1.1
—
—
—
0
0
28
183
1.58
1.40
1.2
2.9
64.83
67.19
g/l
0.94
23
170
37
259
1.48
1.36
1.3
1.3
122.17
141.37
u/ml
0.09
15
100
137
1179
1.27
1.36
2.0
1.9
1.56
1.34
mmol/l
1.42
97
1012
11
54
2.07
1.34
1.1
4.6
41.58
69.17
mg/l
—
5
49
11
54
2.07
1.34
1.1
4.7
29.82
31.12
mg/l
—
5
49
224
2048
1.28
1.34
3.6
3.5
—
—
—
0
0
31
210
1.52
1.33
1.6
1.2
133.26
394.53
u/ml
1.13
31
190
5
18
2.80
1.29
1.4
1.2
—
—
—
0
0
15
85
1.80
1.25
1.2
1.4
—
—
—
0
0
25
165
1.56
1.21
3.8
3.5
95.00
76.00
ng/l
0.48
16
145
13
71
1.86
1.21
1.5
1.2
—
—
—
0
0
10
50
2.03
1.17
1.9
1.5
—
—
—
0
0
15
87
1.76
1.17
1.7
2.0
2.82
5.31
iu/l
—
10
34
10
51
1.99
1.12
1.1
4.3
1.28
4.94
ratio
—
5
29
17
264
0.62
1.08
1.8
1.6
866.15
1004.43
mu/l
0.32
17
221
5
22
2.29
1.03
1.0
1.5
—
—
—
0
0
15
91
1.68
1.02
1.6
1.3
—
—
—
0
0
26
181
1.47
1.02
1.6
1.3
25.92
19.85
iu/l
0.31
20
153
7
133
0.52
1.01
1.0
1.1
1.58
1.55
g/l
—
7
133
7
135
0.51
1.00
1.0
1.1
0.74
0.89
g/l
—
7
135
9
50
1.82
0.97
1.4
1.2
—
—
—
0
0
35
261
1.38
0.96
2.5
2.4
31.10
30.53
u/l
0.07
29
218
67
550
1.27
0.96
1.8
1.5
—
—
—
0
0
9
51
1.79
0.95
1.7
1.4
—
—
—
0
0
6
28
2.16
0.92
1.3
1.6
—
—
—
0
0
6
28
2.16
0.92
1.3
1.6
—
—
—
0
0
6
29
2.09
0.89
1.3
1.6
—
—
—
0
0
6
29
2.09
0.89
1.3
1.6
—
—
—
0
0
6
29
2.09
0.89
1.5
1.6
—
—
—
0
0
6
29
2.09
0.89
1.5
1.6
—
—
—
0
0
286
2743
1.29
0.89
5.3
4.5
1.44
1.48
mmol/l
0.90
263
2578
287
2756
1.29
0.87
5.4
4.6
4.48
4.68
mmol/l
2.95
264
2601
320
3125
1.54
0.85
36.8
20.2
261.08
255.45
e9/l
0.80
315
3074
20
138
1.48
0.83
5.0
8.0
15.01
15.86
%
0.36
20
130
320
3127
1.52
0.82
36.8
20.2
4.49
4.51
e12/l
0.33
315
3062
290
2794
1.28
0.81
5.7
5.1
2.64
2.76
mmol/l
1.54
265
2630
20
140
1.46
0.79
1.6
1.6
—
—
—
0
0
7
38
1.86
0.74
1.3
1.2
—
—
—
0
0
15
217
0.68
0.73
1.1
1.4
—
—
—
0
0
12
76
1.60
0.72
1.9
2.5
8.23
10.91
mg/l
0.95
12
71
5
28
1.80
0.66
5.2
1.8
12.80
13.30
%
—
5
28
23
172
1.36
0.65
1.1
1.0
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
152.68
—
0
20
76
666
1.18
0.60
2.2
2.6
314.73
332.70
umol/l
0.85
64
600
7
115
0.60
0.59
1.3
1.4
—
—
—
0
0
31
249
1.27
0.56
3.3
5.0
3.23
8.95
ug/l
1.99
22
202
58
667
0.84
0.54
2.6
2.2
—
—
—
0
0
55
477
1.18
0.50
5.9
3.4
66.61
314.20
ng/l
1.53
36
335
8
121
0.65
0.46
1.6
2.0
—
—
—
0
0
5
31
1.62
0.43
2.0
4.5
—
—
—
0
0
61
683
0.87
0.42
6.5
3.8
1.02
1.02
kg/l
0.40
41
438
5
33
1.52
0.41
1.2
1.2
—
13.02
—
0
17
0
16
0.00
0.41
0.0
1.1
—
43.76
—
0
16
0
17
0.00
0.41
0.0
1.2
—
164.19
—
0
17
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
13
98
1.34
0.38
3.1
2.1
—
—
—
0
0
49
433
1.15
0.37
3.6
2.7
3.54
2.90
e6/l
0.20
28
201
12
91
1.33
0.34
3.0
1.8
—
—
—
0
0
7
53
1.33
0.31
1.0
1.4
—
—
—
0
0
14
174
0.80
0.30
1.4
1.3
—
—
—
0
0
12
93
1.30
0.30
1.3
1.5
47.98
51.42
ug/l
0.16
12
93
46
510
0.89
0.29
3.6
4.3
17.29
22.03
%
2.04
17
235
10
129
0.77
0.28
1.4
1.4
—
—
—
0
0
10
76
1.33
0.28
1.0
1.2
—
9.52
—
0
11
10
76
1.33
0.28
1.0
1.3
—
62.59
—
0
12
24
274
0.87
0.23
5.0
5.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
345.20
—
0
5
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
210.00
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
56
523
1.08
0.19
2.8
2.2
—
—
—
0
0
77
729
1.07
0.18
2.2
1.7
—
—
—
0
0
50
465
1.09
0.18
3.8
2.7
0.67
0.85
e6/l
0.34
27
233
7
58
1.21
0.18
1.9
1.1
—
—
—
0
0
32
349
0.91
0.16
2.8
2.2
—
—
—
0
0
6
77
0.78
0.16
1.5
1.2
—
—
—
0
0
68
646
1.07
0.15
4.2
5.0
13.45
2.42
ug/l
0.47
61
584
9
81
1.11
0.15
2.8
3.5
23.99
24.58
mmol/l
—
9
75
6
58
1.04
0.08
1.0
1.9
—
—
—
0
0
5
60
0.83
0.08
4.6
6.9
—
545.25
—
0
8
12
108
1.12
0.07
1.6
1.4
—
—
—
0
0
29
296
0.98
0.00
2.6
2.1
—
—
—
0
0
11
109
1.01
0.00
1.8
1.9
—
—
—
0
0
38
379
1.00
0.00
2.9
2.9
0.44
0.79
ug/l
6.14
21
225
57
565
1.01
0.00
2.9
2.4
—
—
—
0
0
12
116
1.04
0.00
1.8
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
43.72
—
0
5
0
5
0.00
0.00
0.0
5.6
—
5.96
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
61.13
—
0
7
7
77
0.91
-0.00
1.0
1.3
—
1.00
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
63.32
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
0.25
—
0
7
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
78
0.90
-0.00
1.1
1.2
—
—
—
0
0
8
79
1.01
-0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SYMPTOMS_SIGNS_INVOLVI_APPEA_BEHVI – Symptoms and signs involving appearance and behaviour
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).